Holen Sie sich die Stockscreener-App
426.00
0.10%
0.43
Vorhandelsmarkt:
410.50
-15.50
-3.64%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
Bank of New York Mellon Corp Lowers Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Bank of Montreal Can Sells 50,652 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Exit strategy if you’re trapped in Vertex Pharmaceuticals IncorporatedJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Vertex Pharmaceuticals (VRTX) Reports Strong Q3 2025 Earnings with 11% Revenue Growth - GuruFocus
Vertex Pharmaceuticals Reports Strong Q3 2025 Results - TipRanks
Why Vertex Pharmaceuticals Incorporated (VX1) stock signals breakout potential - newser.com
Vertex Reports Third Quarter 2025 Financial Results - BioSpace
Vertex Pharmaceuticals Outpaces Expectations With Fresh Growth - Finimize
Vertex’s cystic fibrosis sales beat expectations, as newer drugs miss - The Boston Globe
Vertex Pharmaceuticals (VRTX) Beats Q3 Expectations, Shares Fall - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock: Strong Q3 Results Drive 11% Revenue Growth - parameter.io
Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com
Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily
Vertex falls despite Q3 double beats as 2025 revenue guidance narrowed - Seeking Alpha
Vertex’s Cystic Fibrosis Sales Beat, as Newer Drugs Miss - Bloomberg.com
Vertex Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Vertex Pharmaceuticals (VRTX) Q3 Earnings Surpass Expectations - GuruFocus
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Vertex Pharmaceuticals Grows Past Cystic Fibrosis With New Hits - Finimize
Vertex beats quarterly estimates on cystic fibrosis demand, new drugs - MSN
Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs - MarketScreener
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations - Yahoo Finance
Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book - MSN
After pain setback, Vertex spotlights renal portfolio in expectation-beating Q3 - FirstWord Pharma
Earnings Flash (VRTX) Vertex Pharmaceuticals Incorporated Posts Q3 Adjusted EPS $4.80 per Share, vs. FactSet Est of $4.58 - MarketScreener
Earnings Flash (VRTX) Vertex Pharmaceuticals Posts Q3 Adjusted EPS $4.80, vs. FactSet Est of $4.58 - MarketScreener
Vertex Beats Estimates on Strong Sales of Cystic Fibrosis Drugs - Bloomberg.com
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain. - MSN
Visual analytics tools that track Vertex Pharmaceuticals Incorporated performanceWeekly Trade Report & Smart Investment Allocation Tips - newser.com
Is Vertex Pharmaceuticals Incorporated stock a safe investment in uncertain marketsJuly 2025 Macro Moves & Verified Entry Point Signals - newser.com
Published on: 2025-11-03 07:39:53 - newser.com
Can machine learning forecast Vertex Pharmaceuticals Incorporated recoveryPortfolio Update Report & Safe Capital Investment Plans - newser.com
Will Vertex Pharmaceuticals Incorporated benefit from macro trends2025 Analyst Calls & Growth Focused Entry Reports - newser.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Tredje AP fonden - MarketBeat
Telos Capital Management Inc. Increases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Torray Investment Partners LLC Grows Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Welch & Forbes LLC - MarketBeat
South Dakota Investment Council Sells 10,780 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Published on: 2025-11-03 04:36:10 - newser.com
Mission Wealth Management LP Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated’s volatility index tracking explainedEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Arkadios Wealth Advisors - MarketBeat
Vertex Pharmaceuticals (VRTX): Exploring Valuation After Promising Kidney Therapy Results and Growth in New Treatments - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Holdings Reduced by China Universal Asset Management Co. Ltd. - MarketBeat
Syverson Strege & Co Makes New $283,000 Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Keybank National Association OH Sells 1,523 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Published on: 2025-11-02 03:14:13 - newser.com
Momentum divergence signals in Vertex Pharmaceuticals Incorporated chartTrade Volume Report & Capital Protection Trade Alerts - newser.com
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Vertex Pharmaceuticals Incorporated (VRTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
VERTEX PHARMACEUTICALS Earnings Preview: Recent $VRTX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Top Biotech Stocks To Keep An Eye OnOctober 28th - MarketBeat
1.47%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):